1. Home
  2. VVOS vs NRXS Comparison

VVOS vs NRXS Comparison

Compare VVOS & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VVOS
  • NRXS
  • Stock Information
  • Founded
  • VVOS 2016
  • NRXS 2011
  • Country
  • VVOS United States
  • NRXS United States
  • Employees
  • VVOS N/A
  • NRXS N/A
  • Industry
  • VVOS Medical Specialities
  • NRXS
  • Sector
  • VVOS Health Care
  • NRXS
  • Exchange
  • VVOS Nasdaq
  • NRXS Nasdaq
  • Market Cap
  • VVOS 19.4M
  • NRXS 17.3M
  • IPO Year
  • VVOS 2020
  • NRXS 2023
  • Fundamental
  • Price
  • VVOS $5.02
  • NRXS $2.69
  • Analyst Decision
  • VVOS Strong Buy
  • NRXS
  • Analyst Count
  • VVOS 2
  • NRXS 0
  • Target Price
  • VVOS $6.30
  • NRXS N/A
  • AVG Volume (30 Days)
  • VVOS 231.4K
  • NRXS 27.7K
  • Earning Date
  • VVOS 11-14-2024
  • NRXS 11-12-2024
  • Dividend Yield
  • VVOS N/A
  • NRXS N/A
  • EPS Growth
  • VVOS N/A
  • NRXS N/A
  • EPS
  • VVOS N/A
  • NRXS N/A
  • Revenue
  • VVOS $14,581,000.00
  • NRXS $2,456,219.00
  • Revenue This Year
  • VVOS $12.35
  • NRXS $383.16
  • Revenue Next Year
  • VVOS $26.02
  • NRXS N/A
  • P/E Ratio
  • VVOS N/A
  • NRXS N/A
  • Revenue Growth
  • VVOS 0.54
  • NRXS N/A
  • 52 Week Low
  • VVOS $1.91
  • NRXS $2.00
  • 52 Week High
  • VVOS $12.83
  • NRXS $3.89
  • Technical
  • Relative Strength Index (RSI)
  • VVOS 60.64
  • NRXS 37.79
  • Support Level
  • VVOS $4.45
  • NRXS $2.72
  • Resistance Level
  • VVOS $5.12
  • NRXS $2.49
  • Average True Range (ATR)
  • VVOS 0.49
  • NRXS 0.34
  • MACD
  • VVOS 0.00
  • NRXS -0.04
  • Stochastic Oscillator
  • VVOS 55.33
  • NRXS 8.74

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About NRXS Neuraxis Inc.

Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).

Share on Social Networks: